Equity Overview
Price & Market Data
Price: $3.31
Daily Change: +$0.08 / 2.42%
Daily Range: $3.14 - $3.31
Market Cap: $13,832,670
Daily Volume: 14,943
Performance Metrics
1 Week: -1.78%
1 Month: -2.65%
3 Months: -17.66%
6 Months: -36.10%
1 Year: -65.52%
YTD: -63.22%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.